Cargando…

Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies

Type 2 diabetes mellitus (T2DM) is a growing public health challenge for Thailand (current prevalence ~10.0%). Amino acids offer novel biomarkers to predict risk of T2DM and indicate sub-optimal disease management, which could facilitate earlier treatment. We studied amino acid profiles in a Thai co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sriboonvorakul, Natthida, Pan-Ngum, Wirichada, Poovorawan, Kittiyod, Muangnoicharoen, Sant, Quinn, Lauren M., Tan, Bee K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621185/ https://www.ncbi.nlm.nih.gov/pubmed/34830706 http://dx.doi.org/10.3390/jcm10225424

Ejemplares similares

Assessment of the amino acid profile in Thai patients with type 2 diabetes mellitus using liquid chromatography-mass spectrometry
por: Sriboonvorakul, Natthida, et al.
Publicado: (2020)

Diabetes mellitus in the young: Gliptins or sulfonylurea after metformin?
por: Muthukrishnan, J., et al.
Publicado: (2012)

Determination of ceftriaxone in human plasma using liquid chromatography–tandem mass spectrometry
por: Wongchang, Thamrong, et al.
Publicado: (2022)

Characteristics and associated factors of acute kidney injury among adult dengue patients: A retrospective single-center study
por: Diptyanusa, Ajib, et al.
Publicado: (2019)

The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study
por: Sobhonslidsuk, Abhasnee, et al.
Publicado: (2016)

Clinical Characteristics of Acute Kidney Injury Associated with Tropical Acute Febrile Illness
por: Omar, Fardosa Dahir, et al.
Publicado: (2023)

Mortality in Thai Nursing Homes Based on Antimicrobial-Resistant Enterobacterales Carriage and COVID-19 Lockdown Timing: A Prospective Cohort Study
por: Ngamprasertchai, Thundon, et al.
Publicado: (2022)

Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide study
por: Chaiteerakij, Roongruedee, et al.
Publicado: (2017)

Thirty‐Day Readmission and Cost Analysis in Patients With Cirrhosis: A Nationwide Population‐Based Data
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2020)

Starting with low dose sulfonylurea and metformin in early stage type 2 diabetes mellitus
por: George, Joe
Publicado: (2015)

Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma
por: Toomey, Paul, et al.
Publicado: (2017)

Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODY
por: Oosterom, Nicole, et al.
Publicado: (2022)

Metformin inhibits Branched Chain Amino Acid (BCAA) derived ketoacidosis and promotes metabolic homeostasis in MSUD
por: S. Sonnet, Davis, et al.
Publicado: (2016)

Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes
por: Kwon, Christina S., et al.
Publicado: (2018)

Improvements in Glycemic Control in Type 2 Diabetes Patients Switched From Sulfonylurea Coadministered With Metformin to Glyburide-Metformin Tablets
por: Duckworth, Wiliam
Publicado: (2003)

Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era
por: Poovorawan, Kittiyod, et al.
Publicado: (2016)

Nephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in Thailand
por: Thu, Aung Myint, et al.
Publicado: (2015)

Health care burden and mortality of acute on chronic liver failure in Thailand: a nationwide population-based cohort study
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2022)

Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients
por: Susilawati, Elis, et al.
Publicado: (2023)

Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)
por: Komajda, Michel, et al.
Publicado: (2008)

Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas
por: Mamtani, Ronac, et al.
Publicado: (2014)

Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma: erratum
Publicado: (2017)

The Effectiveness and Safety of Metformin Compared to Sulfonylureas in Diabetic Nephropathy: A Systematic Review
por: Boddepalli, Chinmayi Sree, et al.
Publicado: (2022)

Factors affecting mortality and resource use for hospitalized patients with cirrhosis: A population-based study
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2017)

Severity of COVID-19 in Patients with Diarrhoea: A Systematic Review and Meta-Analysis
por: Dhakal, Sunita, et al.
Publicado: (2023)

Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand
por: Janekrongtham, Chawisar, et al.
Publicado: (2023)

Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study
por: Roumie, Christianne L., et al.
Publicado: (2017)

Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas
por: Chu, Patricia Y., et al.
Publicado: (2020)

Development of Osteoarthritis in Adults With Type 2 Diabetes Treated With Metformin vs a Sulfonylurea
por: Baker, Matthew C., et al.
Publicado: (2023)

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus
por: Gordon, Jason, et al.
Publicado: (2016)

Modeling household dynamics on Respiratory Syncytial Virus (RSV)
por: Mahikul, Wiriya, et al.
Publicado: (2019)

A Population Dynamic Model to Assess the Diabetes Screening and Reporting Programs and Project the Burden of Undiagnosed Diabetes in Thailand
por: Mahikul, Wiriya, et al.
Publicado: (2019)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis
por: Mahikul, Wiriya, et al.
Publicado: (2019)

An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia
por: Fonseca, V, et al.
Publicado: (2011)

Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients
por: Wang, Fei, et al.
Publicado: (2017)

Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials
por: Gebrie, Desye, et al.
Publicado: (2021)

Proteomics Studies in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Sriboonvorakul, Natthida, et al.
Publicado: (2022)

Treatment progression in sulfonylurea and dipeptidyl peptidase-4 inhibitor cohorts of type 2 diabetes patients on metformin
por: Peng, Xiaomei, et al.
Publicado: (2016)

Effectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: a systematic review and meta-analysis
por: Sharma, Manuj, et al.
Publicado: (2017)

Additional Effect of Dietary Fiber in Patients with Type 2 Diabetes Mellitus Using Metformin and Sulfonylurea: An Open-Label, Pilot Trial
por: Lee, Seung-Eun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qkrqlmreisuju72fhmqkgcnvjh